1355347-36-2

Upstream product

• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 3885-45-8 ethyl 2,3-dioxo-3-phenylpropanoate 
• 1355347-34-0 ethyl 2-tert-butyl-5-phenyl-1H-imidazole-4-carboxylate 
• 1355347-35-1 ethyl 2-tert-butyl-1-methyl-4-phenyl-1H-imidazole-5-carboxylate 

Downstream Products

• 1355346-42-7 1-(2-tert-butyl-1-methyl-4-phenyl-1H-imidazol-5-yl)-3-[4-(6,7-dimethoxyquinolin-4-yloxy)phenyl]urea 

Relevant academic research and scientific papers

NITROGENATED AROMATIC HETEROCYCLIC RING DERIVATIVE

The present invention provides a nitrogen-containing aromatic heterocyclic derivative represented by formula (I): [wherein W represents CR3 (wherein R3 represents a hydrogen atom or the like) or the like, R4 represents a hydrogen atom or the like, R5 represents a hydrogen atom or the like, R9 represents substituted imidazolyl, R12 and R13 may be the same or different, each represent a hydrogen atom or the like, R22 and R23 may be the same or different, each represent a hydrogen atom or the like, R24 represents a hydrogen atom or the like, Y represents C-R25 (wherein R25 represents a hydrogen atom or the like) or the like] or a pharmaceutically acceptable salt thereof and a FGFR inhibitor comprising, as an active ingredient, the nitrogen-containing aromatic heterocyclic derivative or the pharmaceutically acceptable salt thereof, or the like.